AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹3,486 Cr | ₹3,173 Cr | ₹1,928 Cr | ₹2,648 Cr | ₹5,335 Cr |
What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹3,486 Cr |
| Mar2024 | ₹3,173 Cr |
| Mar2023 | ₹1,928 Cr |
| Mar2022 | ₹2,648 Cr |
| Mar2021 | ₹5,335 Cr |
How is Consolidated Net Profit of AUROBINDO PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,486 Cr | 9.86 | |
| Mar2024 | ₹3,173 Cr | 64.62 | |
| Mar2023 | ₹1,928 Cr | -27.21 | |
| Mar2022 | ₹2,648 Cr | -50.36 | |
| Mar2021 | ₹5,335 Cr | - | |
Compare Consolidated Net Profit of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹73,703.5 Cr | -3.4% | 7.1% | 16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -3.4% |
7.1% |
16.3% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses